Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Watkins

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Chest|March 26, 2009
Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injuryColin R Cooke, Jeremy M Kahn, Timothy R Watkins, et al.
The American Journal of Cardiology|March 5, 2003
Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart diseaseDennis L Sprecher, Timothy R Watkins, Solomon Behar, et al.
Journal of Clinical Pharmacology|March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver DiseaseIslam R Younis, Elijah J Weber, Cara Nelson, et al.
Journal of Clinical Pharmacology|March 23, 2024
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic ImpairmentIslam R Younis, Cara Nelson, Elijah J Weber, et al.
Clinical Pharmacokinetics|September 18, 2024
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA CarboxylaseElijah J Weber, Islam R Younis, Cara Nelson, et al.
JAMA|August 19, 2010
Prediction of critical illness during out-of-hospital emergency careChristopher W Seymour, Jeremy M Kahn, Colin R Cooke, et al.
Critical Care Medicine|April 14, 2010
Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trialsColin R Cooke, Sara E Erickson, Timothy R Watkins, et al.
Clinical Pharmacology in Drug Development|September 29, 2020
Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy VolunteersRebecca Begley, Kacey Anderson, Timothy R Watkins, et al.
Critical Care (London, England)|September 23, 2011
Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shockElizabeth C Parsons, Catherine L Hough, Christopher W Seymour, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial VirusDanielle P Porter, Ying Guo, Jason Perry, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Chest|March 26, 2009
Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injuryColin R Cooke, Jeremy M Kahn, Timothy R Watkins, et al.
The American Journal of Cardiology|March 5, 2003
Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart diseaseDennis L Sprecher, Timothy R Watkins, Solomon Behar, et al.
Journal of Clinical Pharmacology|March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver DiseaseIslam R Younis, Elijah J Weber, Cara Nelson, et al.
Journal of Clinical Pharmacology|March 23, 2024
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic ImpairmentIslam R Younis, Cara Nelson, Elijah J Weber, et al.
Clinical Pharmacokinetics|September 18, 2024
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA CarboxylaseElijah J Weber, Islam R Younis, Cara Nelson, et al.
JAMA|August 19, 2010
Prediction of critical illness during out-of-hospital emergency careChristopher W Seymour, Jeremy M Kahn, Colin R Cooke, et al.
Critical Care Medicine|April 14, 2010
Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trialsColin R Cooke, Sara E Erickson, Timothy R Watkins, et al.
Clinical Pharmacology in Drug Development|September 29, 2020
Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy VolunteersRebecca Begley, Kacey Anderson, Timothy R Watkins, et al.
Critical Care (London, England)|September 23, 2011
Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shockElizabeth C Parsons, Catherine L Hough, Christopher W Seymour, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial VirusDanielle P Porter, Ying Guo, Jason Perry, et al.
Pageof 6